Pelthos Therapeutics, Inc. (PTHS)
31.00
+3.51
(+12.77%)
USD |
NYAM |
Dec 31, 16:00
31.20
+0.20
(+0.65%)
After-Hours: 20:00
Pelthos Therapeutics Market Cap: 20.45M for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ligand Pharmaceuticals, Inc. | 3.721B |
| Agenus, Inc. | 106.79M |
| Travere Therapeutics, Inc. | 3.419B |
| Inhibrx Biosciences, Inc. | 1.144B |
| Palvella Therapeutics, Inc. | 1.239B |
Market Cap Related Metrics
| PS Ratio | 10.58 |
| PEG Ratio | -0.0029 |
| Price to Book Value | 0.351 |
| Price | 31.00 |
| Earnings Yield | -45.78% |
| PEGY Ratio | -0.0029 |